Physician profile
Wanda I Solis
NPI 1881681211
$976.65
in general payments reported to CMS, 2019-2025
18 companies · $486 in 2025
The $486 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.02 · 2020: $14.51 · 2021: $39.52 · 2022: $106 · 2023: $73.13 · 2024: $208 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $162.88 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $146.18 | 2024-2025 | |
| Glaxosmithkline, LLC. | $133.73 | 2023-2025 | Bexsero, Pediarix, Penmenvy |
| Corium, LLC | $115.92 | 2025 | Azstarys |
| Pfizer INC. | $63.72 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $59.58 | 2025 | Jornay Pm |
| Seqirus USA INC | $54.56 | 2021-2025 | Flucelvax |
| Ironshore Pharmaceuticals INC. | $47.20 | 2024 | |
| Sobi, INC | $35.77 | 2022 | |
| Merck Sharp & Dohme LLC | $32.42 | 2022-2024 | Vaxneuvance, Vaqta, Gardasil 9 |
| Cumberland Pharmaceuticals, INC. | $24.51 | 2019-2021 | |
| Verrica Pharmaceuticals INC. | $20.29 | 2024 | Ycanth |
| Phadia US INC. | $19.62 | 2025 | Immunocap |
| Ultragenyx Pharmaceutical INC. | $12.49 | 2022 | |
| Mission Pharmacal Company | $12.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11.97 | 2024 | |
| Mylan Pharmaceuticals INC. | $11.94 | 2019 | |
| Sanofi Pasteur INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.